| |
Latest 10 SEC filings (by transaction date) for NERV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Oct 5/23 | Oct 4/23 | Luthringer Remy | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 100,450 | |
Oct 5/23 | Oct 4/23 | Race Geoff | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 87,050 | |
Oct 5/23 | Oct 4/23 | Ahlholm Frederick W | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 42,850 | |
Sep 29/23 | Sep 27/23 | Hasler Hans Peter | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Van Heek G Jan | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Hilleman Jeryl L | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Kupfer David | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Laghrissi-Thode Fouzia | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Jul 7/23 | Jul 7/23 | Boehringer Ingelheim International Gmbh | Direct Ownership | Pre-Funded Warrant (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jul 7/23 | Jul 7/23 | Boehringer Ingelheim International Gmbh | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for NERV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Oct 5/23 | Oct 4/23 | Luthringer Remy | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 100,450 | |
Oct 5/23 | Oct 4/23 | Race Geoff | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 87,050 | |
Oct 5/23 | Oct 4/23 | Ahlholm Frederick W | Direct Ownership | Employee Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 42,850 | |
Sep 29/23 | Sep 27/23 | Hasler Hans Peter | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Van Heek G Jan | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Hilleman Jeryl L | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Kupfer David | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Sep 29/23 | Sep 27/23 | Laghrissi-Thode Fouzia | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 12,500 | |
Jul 7/23 | Jul 7/23 | Boehringer Ingelheim International Gmbh | Direct Ownership | Pre-Funded Warrant (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jul 7/23 | Jul 7/23 | Boehringer Ingelheim International Gmbh | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |